Get the latest news, events and publications from Helixomer here.
July 2, 2026
Hex01 and Hex02 Clear Non-GLP Toxicology: On Track for IND
June 19, 2026
Hex01 Achieves Surgical-Range Half-life Without PEG
May 29, 2026
In biotech, “being right” is the wrong goal
May 15, 2026
Helixomer Completes Landmark Study: Hex01 Shows Cross-Species Efficacy, Antiplatelet Activation Activity, and a Clear Path to IND to Finally Replace Heparin-Protamine
May 8, 2025
🔬 Advancing RNA Nanotechnology at FNANO 2025
May 2, 2025
🤠 The cowboy’s back on stage—this time at the Seed2Table Showcase!
April 25, 2025
Standout Moment at Venture Connect 2025!
December 2, 2024
SynBioBeta: Fabricating Nanostructures with RNA Origami
October 14, 2024
Podcast: Life Science Solution by Kymanox: How RNA Origami is Revolutionizing Drug Development
October 7, 2024
Helixomer: Pioneering RNA Origami to Revolutionize Safe and Effective Anticoagulation
July 3, 2024
Research Article: Next-Generation Anticoagulation Platform: Fast-Acting RNA Origami and DNA Reversal Agent Unveiled
May 17, 2024
Helixomer on Stage: FNANO 2024
May 11, 2024
Innovative RNA Origami Anticoagulant Research Highlighted at MSE100 Centennial Celebration
April 5, 2024
Helixomer Inc. Secures $2 Million NIH Award for Development of Innovative Intravenous Anticoagulant and Reversal Agent
April 4, 2024
David Harrell Appointed as New President and CEO of Helixomer
March 21, 2024
DASH STARTUP: NCSU startup nets $2M for next-gen clotting, bleeding control drugs.
December 14, 2023
Helixomer awarded $2M NIH grant for anticoagulant development
December 11, 2023
MSE Startup Helixomer Receives $2M NIH Grant to Advance Breakthrough Anticoagulant and Reversal Agent
July 5, 2023
Book Chapter: Reminiscences from the Trenches: The Early Years of DNA Nanotech
May 15, 2023
Book Chapter: RNA Origami in Action — Our Science Behind Helixomer's Technology
June 22, 2021
Chemical Reviews: Advancing Precision Medicine with Self-Assembling Nucleic Acid Nanostructures
April 21, 2021
October 1, 2020
Pre-print: A Draft of Our Next Paper Has Been Posted to Biorxiv.
July 29, 2020
We Have Received a Chancellor’s Innovation Fund (CIF) Award
February 27, 2020
Research Article: We Recently Published a Peer-Reviewed Research Article on Our Rna Anticoagulant Technology
.jpg)
